Jiang Y - Search Results

1

Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling.

Chen D, Cao Y, Tang H, Zang L, Yao N, Zhu Y, Jiang Y, Zhai S, Liu Y, Shi M, Zhao S, Wang W, Wen C, Peng C, Chen H, Deng X, Jiang L, Shen B. Chen D, et al. Among authors: jiang l, jiang y. Theranostics. 2023 May 27;13(10):3290-3309. doi: 10.7150/thno.84978. eCollection 2023. Theranostics. 2023. PMID: 37351165 Free PMC article.

2

Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1.

Jiang Y, He R, Jiang Y, Liu D, Tao L, Yang M, Lin C, Shen Y, Fu X, Yang J, Li J, Huo Y, Hua R, Liu W, Zhang J, Shen B, Zhang Z, Sun Y. Jiang Y, et al. Cell Death Dis. 2019 Dec 11;10(12):948. doi: 10.1038/s41419-019-2072-5. Cell Death Dis. 2019. PMID: 31827081 Free PMC article.

3

Mycophenolate mofetil preconditioning protects mouse liver against ischemia/reperfusion injury in wild type and toll-like receptor 4 knockout mice.

Xiong C, Du Z, Zhu Y, Xue M, Jiang Y, Zhong Y, Jiang L, Chen H, Shi M. Xiong C, et al. Among authors: jiang l, jiang y. Transpl Immunol. 2021 Apr;65:101357. doi: 10.1016/j.trim.2020.101357. Epub 2020 Dec 3. Transpl Immunol. 2021. PMID: 33279598

4

Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition.

Xiong C, Zhu Y, Xue M, Jiang Y, Zhong Y, Jiang L, Shi M, Chen H. Xiong C, et al. Among authors: jiang l, jiang y. Aging (Albany NY). 2021 Jan 10;13(3):3386-3404. doi: 10.18632/aging.202264. Epub 2021 Jan 10. Aging (Albany NY). 2021. PMID: 33428605 Free PMC article.

5

Cystatin B increases autophagic flux by sustaining proteolytic activity of cathepsin B and fuels glycolysis in pancreatic cancer: CSTB orchestrates autophagy and glycolysis in PDAC.

Jiang Y, Han L, Xue M, Wang T, Zhu Y, Xiong C, Shi M, Li H, Hai W, Huo Y, Shen B, Jiang L, Chen H. Jiang Y, et al. Among authors: jiang l. Clin Transl Med. 2022 Dec;12(12):e1126. doi: 10.1002/ctm2.1126. Clin Transl Med. 2022. PMID: 36495123 Free PMC article.

6

Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma.

Jiang Y, Han L, Yang J, Yang M, Zhang J, Xue M, Zhu Y, Xiong C, Shi M, Zhao S, Shen B, Xu Z, Jiang L, Chen H. Jiang Y, et al. Among authors: jiang l. Cancer Immunol Immunother. 2023 Aug;72(8):2701-2716. doi: 10.1007/s00262-023-03438-y. Epub 2023 Apr 25. Cancer Immunol Immunother. 2023. PMID: 37097516 Free PMC article.

7

LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability.

Han L, Jiang Y, Shi M, Gan L, Wu Z, Xue M, Zhu Y, Xiong C, Wang T, Lin X, Shen B, Jiang L, Chen H. Han L, et al. Among authors: jiang l, jiang y. J Transl Med. 2023 Nov 21;21(1):838. doi: 10.1186/s12967-023-04702-6. J Transl Med. 2023. PMID: 37990271 Free PMC article.

8

BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1.

Cao Y, Wang X, Liu Y, Liu P, Qin J, Zhu Y, Zhai S, Jiang Y, Liu Y, Han L, Luo J, Zhang R, Shi M, Wang L, Tang X, Xue M, Liu J, Wang W, Wen C, Deng X, Peng C, Chen H, Cheng D, Jiang L, Shen B. Cao Y, et al. Among authors: jiang l, jiang y. Adv Sci (Weinh). 2024 Feb;11(7):e2306298. doi: 10.1002/advs.202306298. Epub 2023 Dec 8. Adv Sci (Weinh). 2024. PMID: 38064101 Free PMC article.

9

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Yang J, Jiang Y, He R, Liu W, Yang M, Tao L, Fu X, Shen Y, Li J, Liu D, Huo Y, Zhang J, Hua R, Zhang Z, Sun Y. Yang J, et al. Among authors: jiang y. J Immunol Res. 2019 Sep 8;2019:8656282. doi: 10.1155/2019/8656282. eCollection 2019. J Immunol Res. 2019. PMID: 31583260 Free PMC article.

10

Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer.

Zhu LL, Wu Z, Li RK, Xing X, Jiang YS, Li J, Wang YH, Hu LP, Wang X, Qin WT, Sun YW, Zhang ZG, Yang Q, Jiang SH. Zhu LL, et al. Int J Biol Sci. 2021 Jan 1;17(1):107-118. doi: 10.7150/ijbs.49243. eCollection 2021. Int J Biol Sci. 2021. PMID: 33390837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41,212 results

Search Page